Ocular Therapeutix, Inc.OCULNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank69
Studio
Year-over-Year Change

Return on equity

Latest
-40.64%
↓ 132% vs avg
Percentile
P69
Within normal range
Streak
3 yr
Consecutive growthContracting
Average
128.68%
Historical baseline
PeriodValueYoY Change
2025-40.64%+33.8%
2024-61.36%+30.7%
2023-88.59%+55.9%
2022-200.79%-2596.4%
2021-7.45%+96.4%
2020-204.53%-108.6%
20192379.39%+1579.6%
2018-160.81%+33.7%
2017-242.42%-182.0%
2016-85.95%-